A Dynamic Model of Care for Late Onset Cognitive Impairment. Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong

Similar documents
DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Stephen Salloway, M.D., M.S. Disclosure of Interest

TGF-ß1 pathway as a new pharmacological target for neuroprotection in AD. Filippo Caraci

The Primary Care Guide To Understanding The Role Of Diabetes As A Risk Factor For Cognitive Loss Or Dementia In Adults

The role of the vascular system in dementia

Understanding Symptoms, Causes, and Risks for Alzheimer s Disease

Mild Cognitive Impairment (MCI)

Alzheimer s Disease Update: From Treatment to Prevention

8/14/2018. The Evolving Concept of Alzheimer s Disease. Epochs of AD Research. Diagnostic schemes have evolved with the research

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Brain Health and Risk Factors for Dementia

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging

Biomarkers for Alzheimer s disease

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient

Imaging of Alzheimer s Disease: State of the Art

Cognitive ageing and dementia: The Whitehall II Study

METABOLIC SYNDROME, NEUROINFLAMMATION AND COGNITIVE IMPAIRMENT: STATE OF LEVEL OUTPATIENT CLINIC IN ITALY

Type 2 Diabetes and Brain Disease in Older Adults. Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky

Brain imaging for the diagnosis of people with suspected dementia

Depression: An Important Risk Factor for Cognitive Decline

USE OF BIOMARKERS TO DISTINGUISH SUBTYPES OF DEMENTIA. SGEC Webinar Handouts 1/18/2013

Diagnosis and Treatment of Alzhiemer s Disease

Fact Sheet Alzheimer s disease

Dementia and Healthy Ageing : is the pathology any different?

The current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease

#CHAIR2015. Miami, Florida. September 24 26, JW Marriott Miami. Sponsored by

How can the new diagnostic criteria improve patient selection for DM therapy trials

HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE?

Mild Cognitive Impairment

AT RISK, SCI, EMCI: THE ALPHABET SOUP OF PRECLINICAL AND PRODROMAL ALZHEIMER DISEASE

New life Collage of nursing Karachi

Risk Factor Reduction and Dementia Prevalence Deborah E. Barnes, PhD, MPH

Silent Cerebral Strokes: Clinical Outcomes and Management

Roche satellite symposium/educational session CTAD Asia - China Conference Transforming AD in China: From Diagnosis to Treatment

Overview of neurological changes in Alzheimer s disease. Eric Karran

Alzheimer s Disease without Dementia

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

Prevention, health promotion & early intervention in dementia

CSF Aβ1-42 predicts cognitive impairment in de novo PD patients

New diagnostic criteria for Alzheimer s disease and mild cognitive impairment for the practical neurologist

Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues

UNIVERSITY OF CALGARY. Predicting Cognitive Decline in Patients with TIA and Minor Stroke. Muhammad Amlish Munir A THESIS


Moving Targets: An Update on Diagnosing Dementia in the Clinic

Delirium, Apo-E status, and AD CSF biomarkers

UNIVERSITY OF WESTERN ONTARIO

Dementia is not normal aging!

Outline of Lecture 2/13/2018

Post Stroke Cognitive Decline

Therapeutic Benefits of Caregiver Interventions

Vascular and Degenerative Causes of Cognitive Impairment: How are they linked?

Dementia. Assessing Brain Damage. Mental Status Examination

Probable Early-onset Alzheimer s Disease Diagnosed by Comprehensive Evaluation and Neuroimage Studies

Alzheimer's Disease A mind in darkness awaiting the drink of a gentle color.

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

The added value of the IWG-2 diagnostic criteria for Alzheimer s disease

Mild Cognitive Impairment or Mild Neurocognitive Disorder: Implications for Clinical Practice. Hypothesized Key Players in the Pathogenesis of AD

RESEARCH AND PRACTICE IN ALZHEIMER S DISEASE VOL 10 EADC OVERVIEW B. VELLAS & E. REYNISH

November 16-18, 2017 Hotel Monteleone New Orleans, LA. Provided by

Outline. Facts and figures Action plans Early / correct diagnosis Conclusions

Erin Cullnan Research Assistant, University of Illinois at Chicago

ALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey

Memory Matters: Learning Objectives: Synapses, Age, and Health. Neuronal Synapses DISCLOSURE DECLARATION. Cognition and Normal Aging

Dementia, Cognitive Aging Services and Support

Flicker Light-Induced Retinal Vasodilation is Lower in Alzheimer s Disease

Alzheimer s Biomarkers Consortium of Down Syndrome (ABC-DS)

Theme Topics Subtopics. Basic and Translational Science. Development of New Models and Analysis Methods

Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre

KA Toulis, K. Dovas, M. Tsolaki. The endocrine facets of Alzheimer s disease and dementia-related disorders

Objective 4/22/2019. Interaction of Cardiovascular Disease and Alzheimer s Disease: Implications for Cardiopulmonary Rehabilitation.

Interaction of Cardiovascular Disease and Alzheimer s Disease: Implications for Cardiopulmonary Rehabilitation

The Aging Brain The Aging Brain

Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Mary Sano, PhD Mount Sinai School of Medicine James J Peters Veterans Affairs Hospital June 15, 2013

Diabetes Mellitus and Dementia. Andrea Shelton & Adena Zadourian

Mild Cognitive Impairment Symposium January 19 and 20, 2013

Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia

Synaptic changes in dementia: links to cognition and behaviour

The ABCs of Dementia Diagnosis

ALZHEIMER S DISEASE FACTOIDS & STATISTICS

BGS Spring Risk Factors and Preventative Strategies for Dementia

Regulatory Challenges across Dementia Subtypes European View

POST STROKE DEMENTIA: DIAGNOSIS & INTERVENTION. Danielle E. Eagan, Ph.D. Barrow Neurological Institute Stroke Symposium October 13, 2018

Dementia and Alzheimer s disease

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

Evidence-Based Treatments and Community Resources for Persons with Memory Loss. Prevention vs. Treatment

The Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing

Assessing and Managing the Patient with Cognitive Decline

Tammie Benzinger, MD, PhD

Cognitive Reserve In Alzheimer s Disease: Implications for Detection and Prevention

CASE 49. What type of memory is available for conscious retrieval? Which part of the brain stores semantic (factual) memories?

Next patient please Dementia Clare Hawley 2018

An integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

MEDICAL LIFESTYLE INTERVENTIONS FOR BRAIN HEALTH

Form D1: Clinician Diagnosis

Self-Compassion in Taking & Giving Care. Objectives

Alzheimer s Disease Centers meeting San Diego, CA October 14, NIA-Division of Neurosciences update"

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge

Transcription:

A Dynamic Model of Care for Late Onset Cognitive Impairment Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong

Outline The pathogenesis of Late life cognitive impairment A framework of care

The golden age.. Age (Cambridge dictionary) The period of time someone has been alive The Life Cycle Course of developmental changes from inception as fertilized zygote to a mature reproductive state, followed by subsequent decline

At 85 years old, you may experience Reduced motility Reduced interests Forgetfulness Repetitiveness Mini-mental state exam 24/30 Delayed recall 2/10 1 minute animal fluency test 10 examplars

Brain Imaging Serial MRI brain scans, taken six months apart, show progression from mild cognitive impairment to Alzheimer's disease, with significant atrophy (blue) and ventricle enlargement (orange/red). (University of California, San Diego, UCSD)

Brain Imaging Klunk, W.E., et al., Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurology, 2004;55:306-19

Alzheimer s disease

Alzheimer Disease Anatomical diagnosis of Auguste Deter Cerebral atrophy Arteriosclerosis of small blood vessels Presentation by Alzheimer at conference in Tubingen (1906) Fibrils with characteristics thickness (tangles) Small miliary foci (plaques)

Amyloid protein leads to AD. The Amyloid Cascade Hypothesis Amyloid Precursor Protein Aß plaques Aß Aß oligomer Aß Fibrils P-Tau Excitotoxicity Inflammation Oxidation Mitochondrial dysfunction Neurofibrillary tangles Synapse failure, Cell Death Cummings, Alz Dement, 2011

How does Alzheimer s disease develop?

A life course approach AGE Dementia Alzheimer disease

At conception Early onset AD Amyloid precursor gene (21) Presenilin 1 gene (14) Presenilin 2 gene (1) Late onset AD Apolipoprotein E gene (19) Gene dose effects Advance age of onset >200 genes identified Inflammatory pathway, energy metabolism, neuronal repair, estrogen, immune response Tanzi et al., Nature, 1987;329(6135):156-157; Lewy-Lahad et al., Science 1995;269:973-977; Sherrington et al., Nature, 1995;375 (6534):754-760; Corder et al., Science 1993;261(5123):921-923

Early Life Environmental Enrichment Transgenic and wild type mice were either housed under standard conditions or in an enriched environment. Standard housed Transgenic mice Diminished hippocampal cell proliferation Reduced number of mature newborn neurons. Environmental enrichment reversed this genotype effect. Cognitive and physical stimulation Increasing the number of newborn mature hippocampal neurons in transgenic mice. Herring A, Exp Neurol. 2009;216:184-192.

A life course approach Dementia Alzheimer disease

Education High education is a protective factor for the development of dementia. Enhanced cognitive reserve? Higher education delay the onset of decline. Modulate clinical manifestations of disease burden? Valenzuela & Sachdev, Psychol Med, 2006; Wilson et al., Arch Gen Psy, 2007; Rosell F et al., Clin Neurol Neurosurg; Hall CD et al., Neurology, 2007;

Education, the brain and Dementia Population-based cohort studies (Epidemiological Clinicopathological Studies in Europe; EClipSE) 3 population-based studies that included 827 post-mortem brain donation. 1985 and 1991. Longer years in education at early life were associated Decreased dementia risk and greater brain weight No relationship to neurodegeneration. EclipSE Collaborative Members, Brayne C, et al. Brain 2010; 133:2210-6

A life course approach Dementia Alzheimer disease

Early Linguistic Ability - The Nun Study A longitudinal study on aging and disability using antemortem and postmortem data collected from 678 older School Sisters of Notre Dame since 1986. The causes and prevention of Alzheimer's disease, The mental and physical disability associated with old age. Healthy Aging versus dementia AD pathology Stroke Early linguistic ability Education Snowdon. et al., JAMA. 1997;277:813-817; Tyas et al., Age Ageing. 2007;36:650-655.

Occupation In a religious order study of 517 Bavarian school sisters, risk of dementia was associated with Low education (OR 4.5, 95%CI 2.0-9.9) Not having vocational training (OR 9.1, 95% CI 3.9-20.9) Never been appointed to a leading position (OR 3.7, 95% CI 2.0-7.0) Bickel & Kurz, Dement Geriatr Cogn Disord, 2009;27:548-556

A life course approach Dementia Alzheimer disease

Mid Life Body Mass Index and AD In a meta analysis Low BMI, increased risk of AD (OR 1.96, 95% CI:1.32-2.92) Overweight BMI, increased risk of AD (OR 1.35, 1.19-1.54), VaD (OR 1.26, 1.10-1.44) U-shape curve Anstev et al, Obse Rev 2011;12:e426-37

Atherosclerosis and dementia Rotterdam study A population based cohort of over 6600 subjects followed up with a mean of 9 years. Atherosclerosis, especially carotid plaques, are associated with an increased risk for dementia. Van Oijen et al, Ann Neurology, 2007;403-410.

Cognitive activities & cognitive function Cognitive activities (reading, playing board games, musical instruments, dancing) dementia risk Late life cognitive activities delayed onset of accelerated memory decline more rapid decline after onset. Stimulating leisure activities dementia risk and AD over a 4 year period in the Three-City Study in France. Midlife cognitive activity, but not physical activity, modulated risk of dementia in monzygotic twins pairs. Verghese et al., NEJM, 2003; Hall et al., Neurology, 2009; Akbaraly et al., Neurology, 2009; Carlson et al., 2008.

Physical activities & cognitive function Leisure time physical activity lower mortality in a US national cohort. A 24-week home based physical activity intervention provided a modest improvement in cognition over an 18-month followup period. 6 months aerobic exercise associated sex-specific effects on cognition, glucose metabolism and hypothalamic- pituitary adrenal axis. 12 months resistance training improved executive function (Stroop test) over balance and toning. Lautenschlager et al., JAMA, 2008; Gillum & Obisesan, 2010, Ann Epidemiol, 2010; Baker et al., Arch Neurol., 2010; Liu-Ambrose et al., Arch Intern Med., 2010.

A life course approach Dementia Alzheimer disease

Amyloid ß deposition in clinical normal elders Aβ deposition in cognitively normal elders is Age-related Associated with cortical thinning Hippocampal atrophy, Aβ deposition in temporal neocortex are associated with episodic memory loss in pre-dementia stage Becker et al, Ann Neurol, 2011;69:1032-1042 Chetelat et al., Brain 2011;134:798-807

Vascular lesions in AD brains Vascular lesions Major infarcts, lacunes, microbleeds, white matter degeneration Mixed with AD pathology Synergistic effects on clinical symptoms & disease course Jellinger. J Alz Dis., 2008;14:107-123

What determines the development of AD?

Sperling et al, Alz Dementia; 2011

Hypothetical Model of AD Pathophysiological Cascade Jack CR Jr. et al, Lancet Neurol, 2010

A framework of care From prevention to treatment A personalized approach

Primary Prevention From Early to Adult Life AGE Early factors Genes Intelligence Education Occupation Personality Midlife vascular health Exercise, Diet, Lifestyles Brain Lesions Perinatal Care Health Care in early life School Education Social and Leisure enrichment Occupation Safety Substance misuse

Primary Prevention From Mid Life AGE Early factors Genes Intelligence Education Occupation Personality Midlife vascular health Exercise, Diet, Lifestyles Brain Lesions Optimizing cardiovascular and brain health Vascular risks Depression Physical exercise Cognitive activities Social network and support Diet

At Late Life Preclinical & Prodromal Phase AGE Early factors Genes Intelligence Education Occupation Personality Midlife vascular health Exercise, Diet, Lifestyles Brain Lesions Optimizing cardiovascular and brain health Vascular risks Depression Physical exercise Cognitive activities Social network and support Diet Structured approach to intervention?

A personalized approach to dementia care Risk assessment Genetic Physical Health Cognitive reserve Early biomarker changes Intervention Stage dependent Modality Constitutional factors (Pharmacogenetics)

Alzheimer s disease Mild AGE Early factors Genes Intelligence Education Occupation Personality Midlife vascular health Exercise, Diet, Lifestyles Brain Lesions Optimizing physical Health Caregiver involvement Cognitive and functional maintenance Acetylcholine esterase inhibitors Functional training for IADL

Alzheimer s disease Moderate AGE Early factors Genes Intelligence Education Occupation Personality Midlife vascular health Exercise, Diet, Lifestyles Brain Lesions Optimizing physical Health Caregiver involvement Cognitive and functional maintenance Acetylcholine esterase inhibitors/ NMDA receptor antagonist Management of neuropsychiatric symptoms Functional training for BADL Consideration for day training

Alzheimer s disease Severe AGE Early factors Genes Intelligence Education Occupation Personality Midlife vascular health Exercise, Diet, Lifestyles Brain Lesions Optimizing physical Health Caregiver involvement Acetylcholine esterase inhibitors/ NMDA receptor antagonist Management of neuropsychiatric symptoms Support for BADL and physiological function Consideration for long term care

Dynamic model A patient Journey Preclinical Prodromal Clinical Enhancing Cognitive Reserve Attention to brain health Optimizing cognition Reduce psychiatric and physical morbidity Community Health care services Outpatients Hospitals Long term care

To tackle late life cognitive impairment.. Never too early Avoids being too late

Thank you